Abstract
• COVID-19 patients are at increased risk of thromboembolic complications. • Escalated-dose thromboprophylaxis may help reduce the rate of thromboembolic events. • The bleeding risk is highest for patients treated with therapeutic anticoagulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have